The table below shows UroGen Pharma Ltd.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Revenue
$50.96M
$27.48M
$24.21M
$20.25M
$24.57M
$25.20M
Cost of revenue
$4.14M
$3.28M
$3.55M
$2.33M
-
$2.45M
Gross profit
$46.82M
$24.20M
$20.66M
$17.92M
$22.09M
$22.75M
R&D
$15.60M
$14.01M
$18.91M
$19.87M
-
$11.36M
URGN annual revenue (10-K history)
UroGen Pharma Ltd. reported annual revenue of $109.79M for fiscal year 2025. That is up 21.4% from $90.40M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $17.53M (FY 2016) to $109.79M. Figures come from the company's audited annual reports as filed with the SEC.